A systematic review of cohort studies of the quality of life in HIV/AIDS patients after antiretroviral therapy

Jin, Yantao; Liu, Zhibin; Wang, Xin; Liu, Huixin; Ding, Guowei; Su, Yingying; Zhu, Lin; Wang, Ning
October 2014
International Journal of STD & AIDS;Oct2014, Vol. 25 Issue 11, p771
Academic Journal
The aim of this paper was to review cohort studies that analyze changes in the quality of life of people living with HIV/AIDS. We searched the PubMed and EmBase databases from inception to December 2012 for primary cohort studies of the quality of life of people living with HIV/AIDS after combination antiretroviral therapy (cART). Two independent reviewers screened and selected published studies of quality of life that had been followed up for more than 12 weeks after the beginning of cART. Data from the papers were analyzed to identify common characteristics of the effects of cART on the quality of life of HIV/AIDS patients. Eight cohort studies were found: only four were assessed as high quality and four were assessed as moderate quality. None of the studies described patient selection. Six studies followed the patients for one year or more, and the other studies for less than 6 months. Seven studies reported quality of life had been improved after initiation of cART, and one study reported no change. Previous research suggested that cART improved the quality of life of AIDS patients for a limited time, so further research for longer periods is needed to confirm this outcome.


Related Articles

  • Retention in HIV Care between Testing and Treatment in Sub-Saharan Africa: A Systematic Review. Rosen, Sydney; Fox, Matthew P. // PLoS Medicine;Jul2011, Vol. 8 Issue 7, p1 

    Background: Improving the outcomes of HIV/AIDS treatment programs in resource-limited settings requires successful linkage of patients testing positive for HIV to pre-antiretroviral therapy (ART) care and retention in pre-ART care until ART initiation. We conducted a systematic review of pre-ART...

  • Do Men and Women with HIV Differ in Their Quality of Life? A Study from South India. Chandra, Prabha S.; Satyanarayana, Veena A; Satishchandra, P.; Satish, K. S.; Kumar, Mahendra // AIDS & Behavior;Feb2009, Vol. 13 Issue 1, p110 

    This paper examined gender differences in Quality of Life (QOL) among people living with HIV/AIDS in South India using the locally validated version of the WHO Quality of Life Instrument for HIV (WHOQOL-HIV 120). Participants ( N = 109) were men and women with HIV1 Clade C infection...

  • A Social-Ecological View of Barriers and Facilitators for HIV Treatment Adherence: Interviews with Puerto Rican HIV Patients. Castro, Eida M.; Santiago, Lydia E.; Jiménez, Julio C.; Dávila-Vargas, Daira; Rosal, Milagros C. // PLoS ONE;09/30/2015, Vol. 10 Issue 10, p1 

    Purpose: To identify perceived barriers and facilitators for HAART adherence among people living with HIV/AIDS in Southern Puerto Rico using a Social Ecological framework. Patients and Methods: Individual in-depths interviews were conducted with 12 HIV patients with a history of HAART...

  • Assessment of Quality of Life of People Living With HIV/AIDS In Karnataka State. Basavarajaiah, D. M.; Narasimha murthy, B.; Leelavathy, B.; Maheshappa, K. // International Journal of Scientific & Technology Research;Nov2012, Vol. 1 Issue 10, p38 

    HIV not only affects the physical well being of an individual but also the overall Quality of life (QOL) . The assessment of QOL is more important to understanding how the people's lives are affected by HIV infection. It helps to evaluate the financial costs, benefits of new programmes to health...

  • Risk of Melanoma in People with HIV/AIDS in the Pre- and Post-HAART Eras: A Systematic Review and Meta-Analysis of Cohort Studies. Olsen, Catherine M.; Knight, Lani L.; Green, Adèle C. // PLoS ONE;Apr2014, Vol. 9 Issue 4, p1 

    Objective: Following the introduction of highly active antiretroviral therapy (HAART) the risk of AIDS-defining cancers decreased but incidence of many non-AIDS-defining cancers has reportedly increased in those with HIV/AIDS. Whether melanoma risk has also changed in HIV/AIDS patients...

  • Cancer as a Cause of Death among People with AIDS in the United States. Simard, Edgar P.; Engels, Eric A. // Clinical Infectious Diseases;10/15/2010, Vol. 51 Issue 8, p957 

    Background. People with human immunodeficiency virus (HIV) infection and AIDS have an elevated risk for cancer. Highly active antiretroviral therapy (HAART), which has been widely available since 1996, has resulted in dramatic decreases in AIDS-related deaths. Methods. We evaluated cancer as a...

  • Who Still Dies of AIDS, And Why. Taubes, Gary // New York;6/16/2008, p56 

    The article reports on Acquired Immune Deficiency Syndrome (AIDS) patients in the U.S. and profiles AIDS patients, including Mel Cheren and Bob Hattoy. The article discusses the AIDS treatment known as highly active anti-retroviral therapy (HAART) and the positive effect it had on AIDS patients...

  • Antiviral Briefs.  // AIDS Patient Care & STDs;Mar2009, Vol. 23 Issue 3, p219 

    The article offers information of antiviral updates. U.S. Food and Drug Administration (FDA) was given a tentative approval to a fixed-dose combination tablet that contains three antiretrovirals stavudine, lamivudine, and nevirapine. Researchers at the Stanford University School of Medicine in...

  • Evaluating health-related wellbeing outcomes among outpatient adults with human immunodeficiency virus infection in the HAART era. Saunders, Douglas S.; Burgoyne, Robert W. // International Journal of STD & AIDS;Oct2002, Vol. 13 Issue 10, p683 

    Quality of life (QoL) changes among 56 adult patients living with HIV/AID (PHA) were assessed following two years of care in which most had received highly active antiretroviral therapy (HAART). The sample was stratified by initial disease stage; subjects were classified 'asymptomatic' if they...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics